Nemes Rush Group’s Astera Labs ALAB Stock Holding History

Nemes Rush Group’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.5K	Buy	30 +18	+150%	+$4.78K	﹤0.01%	525
2026 Q1	$1.31K	Hold	12	–	–	﹤0.01%	792
2025 Q4	$2K	Buy	+12	New	+$2.01K	﹤0.01%	733

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Nemes Rush Group's ALAB Position: Q2 2026 in Review

Nemes Rush Group increased its Astera Labs (ALAB) stake by 150% in Q2 2026, buying an estimated $4.78K and bringing the position to 30 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #525.

Nemes Rush Group first reported a position in ALAB in Q4 2025 and has held it in 3 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Nemes Rush Group held 30 shares of Astera Labs worth $14.5K as of Q2 2026.
Nemes Rush Group bought 18 Astera Labs shares in Q2 2026, an estimated $4.78K.
Astera Labs made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #525 holding.
Nemes Rush Group first reported a position in Astera Labs in Q4 2025 and has held it in 3 quarters since.
988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.